$MEDP

AI Analysis

Generated on May 11, 2026

AI Score
74/ 100
Hold$MEDP

Medpace Holdings

$MEDPNASDAQHealthcareMid-Cap

Medpace is a clinical contract research organization providing drug and medical device development services.

Market Cap
$10.0B
Revenue (TTM)
$2.1B
+12.0%
Net Income (TTM)
$0.35B
+15.0%
EPS (TTM)
$11.00
P/E Ratio
22.0
Dividend Yield
0.0%
52-Week Range
$260-$440
Beta
0.82
Dimension Scores
Fundamental
72
Technical
70
Sentiment
74
Risk / Reward
72
Momentum
72
FundTechSentRiskMome
Financial Health
Profitability
77strong
Growth
75strong
Liquidity
80strong
Solvency
74strong
Efficiency
70strong

Valuation, technical analysis, investment thesis, risk assessment and more for $MEDP

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.